The University of Colorado-Denver received a $672,011 Project Grant award from the National Cancer Institute's Cancer Biology Research program (CFDA 93.396) to conduct research on how respiratory viral infections, such as influenza and SARS-CoV-2, can promote the awakening and expansion of dormant cancer cells in the lungs, leading to increased metastasis and cancer-related deaths. The research aims to determine the mechanisms by which acute viral infections in the lungs induce the activation of dormant disseminated cancer cells and influence host immune responses, with the goal of informing early detection and prevention strategies for at-risk cancer patients. The 5-year project period runs from Mar 1, 2025 to Feb 28, 2030.
Generated 3/18/25, 3:57 AM